Dying to Survive : The Chinese Film That Turned a Drug-Smuggling Story into a National Conversation
In 2018, Chinese cinema delivered one of its most unexpected and impactful hits: Dying to Survive (Chinese title Wo Bu Shi Yao Shen, roughly “I Am Not a Medicine God”). Directed by Wen Muye in his feature debut and starring comedy star Xu Zheng, the film is a sharp, funny, and deeply moving comedy-drama based on a true story. It became a box-office phenomenon and, more importantly, a rare mainstream Chinese movie that openly tackled the high cost of life-saving medicine.
The Real Story Behind the Film
The movie draws from the experiences of Lu Yong, a Chinese leukemia patient and businessman. In the early 2000s, the patented Swiss drug Gleevec (imatinib) for chronic myeloid leukemia (CML) cost a fortune—tens of thousands of yuan per month, enough to bankrupt ordinary families. A much cheaper generic version was available in India. Lu began importing it not only for himself but eventually for hundreds (and reportedly over a thousand) of fellow patients. He was later arrested on charges related to selling unapproved drugs; public support from patients helped lead to the case being dropped. The film takes this foundation and fictionalizes it for dramatic effect.
Plot Overview (Spoiler-Light)
Xu Zheng plays Cheng Yong, a down-on-his-luck Shanghai shopkeeper who sells dubious Indian “love potions” (herbal aphrodisiacs). His business is failing, his personal life is a mess—divorce, custody issues, an ailing father—and he’s desperate for money. When a leukemia patient approaches him about smuggling the affordable Indian generic of the expensive official CML drug, Cheng sees a business opportunity. What begins as a profit-driven side hustle gradually expands into a makeshift network helping patients who have nowhere else to turn. The tone mixes black comedy, tense cat-and-mouse elements with authorities, and genuine emotional weight as Cheng’s motivations evolve.
The supporting cast, including Wang Chuanjun, Tan Zhuo, Zhang Yu, and Zhou Yiwei, brings warmth and specificity to the patients and associates around Cheng. The film balances humor (often from the ragtag group’s early misadventures) with the harsh realities of illness and financial desperation.
Why It Resonated So Strongly
Dying to Survive landed at a moment when Chinese audiences were hungry for stories that felt grounded and socially relevant. It scored extremely high on Douban (China’s major film rating site), with scores hovering near 9/10 at its peak—rare for a domestic commercial film. It opened to roughly $200 million in its first weekend and ultimately grossed around $450–453 million in China, ranking among the year’s top earners.
Critics and audiences frequently compared it to Dallas Buyers Club, noting the shared premise of ordinary people circumventing official systems to obtain affordable medicine. Yet the Chinese context gives it a distinct flavor: the focus is less on individual outlaw heroism in isolation and more on community, moral ambiguity, and the tension between strict regulations and human need. Director Wen Muye (working with co-writers including Han Jianü and Zhong Wei, and produced by Ning Hao and Xu Zheng) keeps the tone accessible rather than purely didactic. Humor softens the heavier material without undercutting the seriousness of patients facing bankruptcy or death because of drug prices.
Cultural and Policy Impact
The film did more than entertain. It fueled public discussion about healthcare costs and access to cancer treatments in China. Chinese Premier Li Keqiang publicly referenced the movie when urging regulators to accelerate price reductions for cancer drugs and ease the burden on families. In the years that followed, policy moves around generic drugs and reimbursement reflected broader pressure that the film helped amplify. It stands as an example of commercial Chinese cinema engaging with real social pain points while still clearing official channels—something not always easy in the industry.
Performances, Craft, and Lasting Appeal
Xu Zheng delivers a strong lead performance, shifting convincingly from opportunistic everyman to someone changed by the people he meets. The ensemble work is one of the film’s quiet strengths; the patients feel like individuals rather than symbols. Wen’s direction is confident for a debut, blending commercial pacing with moments of real emotional punch. Runtime sits around two hours, and while some international reviews noted occasional repetition or sentimentality, the overall craft and sincerity carried it.
The film collected awards recognition, including honors at the Golden Horse Awards (notably for Wen as best new director and screenplay recognition). It remains one of the clearer demonstrations that Chinese audiences will strongly support stories that treat ordinary people’s struggles with dignity and some humor.
Final Thoughts
Dying to Survive is not a perfect film, and it is not pure documentary. It softens and reshapes the real events for narrative and emotional effect. What it does exceptionally well is humanize a systemic problem—sky-high prices for essential medicines—and show how individual choices ripple outward. It is funny in places, heartbreaking in others, and ultimately hopeful without being naive.
If you are interested in Chinese cinema beyond pure spectacle or historical epics, or if you care about stories that sit at the intersection of health, economics, and ethics, this one is essential viewing. It proves that a film about drug smuggling, leukemia, and moral gray areas can become a genuine crowd-pleaser and leave a mark beyond the theater.
0 Comments